CYCN icon

Cyclerion Therapeutics

Positive
Neutral
Negative
Sentiment 3-Months
Positive
Neutral 100%
Negative

Neutral
Seeking Alpha
21 days ago
Cyclerion Therapeutics, Inc. - Pre Recorded Special Call
Cyclerion Therapeutics, Inc. - Pre Recorded Special Call Company Participants Regina Graul - CEO, President & Director Presentation Regina Graul CEO, President & Director Good morning, everyone. Yesterday, we announced Cyclerion's transformational relaunch as a neuropsychiatric company, supported by an MIT licensing agreement that secures foundational intellectual property.
Cyclerion Therapeutics, Inc. - Pre Recorded Special Call
Neutral
GlobeNewsWire
22 days ago
Cyclerion Announces Transformational Relaunch as a Neuropsychiatric Company
Cyclerion has entered into a licensing agreement with MIT, securing the intellectual property that will serve as the cornerstone of its strategic relaunch.
Cyclerion Announces Transformational Relaunch as a Neuropsychiatric Company
Neutral
GlobeNewsWire
10 months ago
Cyclerion's sGC Stimulator Portfolio Generates Revenues to Enable Company Growth
CAMBRIDGE, Mass., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Cyclerion Therapeutics, Inc. (Nasdaq: CYCN), today announced an update on its progress in catalyzing the Company's next stage of growth.
Cyclerion's sGC Stimulator Portfolio Generates Revenues to Enable Company Growth
Neutral
GlobeNewsWire
1 year ago
Regina Graul, Ph.D., Promoted to Chief Executive Officer
CAMBRIDGE, Mass., Aug. 07, 2024 (GLOBE NEWSWIRE) -- Cyclerion Therapeutics, Inc. (Nasdaq: CYCN), today announced that Regina Graul, Ph.D.
Regina Graul, Ph.D., Promoted to Chief Executive Officer
Neutral
GlobeNewsWire
1 year ago
Cyclerion Appoints Regina Graul, Ph.D., as President
– Dr. Graul will lead the rebuild of Cyclerion, bringing more than two decades of drug making experience, R&D portfolio leadership, and a deep expertise in company strategy –
Cyclerion Appoints Regina Graul, Ph.D., as President
Neutral
GlobeNewsWire
1 year ago
Cyclerion Strengthens Board of Directors with Experienced Company Builder and Cutting-edge Innovator
- Dina Katabi, Ph.D.: World leader in healthcare AI applications at MIT; inventor of groundbreaking wireless devices for passive assessment of symptoms, behavior, and treatment responses in neurological and psychiatric disorders
Cyclerion Strengthens Board of Directors with Experienced Company Builder and Cutting-edge Innovator